Basic Information
RNALocate ID: | RLID:11004369 |
RNA Symbol: | hsa-miR-320d |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-320d |
RNA ID: | miRBase:MIMAT0006764 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 27278097 |
Tissue/Cell Line: | Pooled sera |
Method: | miRNA array |
Condition: | Acute rejection (AR)|Bronchiolitis obliterans syndrome (BOS)|Stable |
Description: | Exosomes were defined by flow cytometry for CD63 and western blotting for annexin V SAgs, collagen V (Col-V) and Kα1 tubulin were examined by electron microscopy; miRNAs were profiled by a miRNA array. The global miRNA analysis demonstrated 123 detectable miRNAs (i.e., at least 1 pool with positive detection signal) in sera exosomes. Of these, 15 miRNAs were higher and 108 miRNAs were lower in AR LTxRs compared to stable LTxRs (Table S1). In contrast, 44 miRNAs were higher and 79 miRNAs were lower in BOS LTxRs compared to stable LTxRs (Table S1). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002800 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:11004370 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11004371 | Exosome | Plasma | 23663360 |
RLID:11004372 | Exosome | Breast cancer cell lines (MCF-7|MDA-MB-231) | 24468161 |
RLID:11004373 | Exosome | Colon cancer cell line (LIM1863) | 25330373 |
RLID:11004374 | Microvesicle | Plasma | 23077538 |
RLID:11004375 | Microvesicle | Seminal plasma | 23539611 |
RLID-D:11000804 | Microvesicle | Fibroblasts|Mesenchymal stem cells | |
RLID-D:11001744 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-320d | Ovarian clear cell carcinoma | MNDR-E-MI-39497 |
MNDR | hsa-miR-320d | Estrogen-receptor positive breast cancer | MNDR-E-MI-39498 |
MNDR | hsa-miR-320d | Estrogen-receptor negative breast cancer | MNDR-E-MI-39499 |
MNDR | hsa-miR-320d | Progesterone-receptor positive breast cancer | MNDR-E-MI-39500 |
MNDR | hsa-miR-320d | Progesterone-receptor negative breast cancer | MNDR-E-MI-39501 |
MNDR | hsa-miR-320d | Her2-receptor positive breast cancer | MNDR-E-MI-39502 |
MNDR | hsa-miR-320d | Prostate cancer | MNDR-E-MI-39503 |
MNDR | hsa-miR-320d | Gastric cancer | MNDR-E-MI-39504 |
MNDR | hsa-miR-320d | Alzheimer disease | MNDR-E-MI-39505 |
MNDR | hsa-miR-320d | Intracranial aneurysm | MNDR-E-MI-39506 |
MNDR | hsa-miR-320d | Cardiovascular disease | MNDR-E-MI-39507 |
MNDR | hsa-miR-320d | Moyamoya disease | MNDR-E-MI-39508 |
MNDR | hsa-miR-320d | Lung cancer | MNDR-E-MI-39509 |
MNDR | hsa-miR-320d | Parkinson disease | MNDR-E-MI-39510 |
MNDR | hsa-miR-320d | Breast cancer | MNDR-E-MI-39511 |
MNDR | hsa-miR-320d | Pancreatic cancer | MNDR-E-MI-39512 |
MNDR | hsa-miR-320d | Nephroblastoma | MNDR-E-MI-39513 |
MNDR | hsa-miR-320d | Colon cancer | MNDR-E-MI-39514 |
MNDR | hsa-miR-320d | Relapsing-remitting multiple sclerosis | MNDR-E-MI-39515 |
MNDR | hsa-miR-320d | Familial ovarian cancer | MNDR-E-MI-39516 |
MNDR | hsa-miR-320d | Prostate adenocarcinoma | MNDR-E-MI-39517 |
MNDR | hsa-miR-320d | Carcinoma ductal breast | MNDR-E-MI-39518 |
MNDR | hsa-miR-320d | Glioblastoma | MNDR-E-MI-39519 |
MNDR | hsa-mir-320d | Glioma | MNDR-E-MI-39520 |
MNDR | hsa-miR-320d | Chronic obstructive pulmonary disease | MNDR-E-MI-39521 |
MNDR | hsa-miR-320d | Chordoma | MNDR-E-MI-39522 |
MNDR | hsa-miR-320d | Pancreatic ductal adenocarcinoma | MNDR-E-MI-39523 |
MNDR | hsa-miR-320d | Lung squamous cell carcinoma | MNDR-E-MI-39524 |
MNDR | hsa-miR-320d | Non-small cell lung adenocarcinoma | MNDR-E-MI-39525 |
MNDR | hsa-miR-320d | Lung adenocarcinoma | MNDR-E-MI-39526 |
MNDR | hsa-miR-320d | Adrenocortical cancer | MNDR-E-MI-39527 |
MNDR | hsa-miR-320d | Thyroid carcinoma | MNDR-E-MI-39528 |
MNDR | hsa-miR-320d | Pancreatic adenocarcinoma | MNDR-E-MI-39529 |
MNDR | hsa-miR-320d | Myasthenia gravis autoimmune experimental | MNDR-E-MI-39530 |
MNDR | hsa-miR-320d | Kidney renal clear cell carcinoma | MNDR-E-MI-39531 |
MNDR | hsa-miR-320d | Renal clear cell carcinoma | MNDR-E-MI-39532 |
MNDR | hsa-miR-320d | Biliary tract cancer | MNDR-E-MI-39533 |
MNDR | hsa-miR-320d | Head and neck squamous cell carcinoma | MNDR-E-MI-39534 |
MNDR | hsa-miR-320d | Breast invasive carcinoma | MNDR-E-MI-39535 |
MNDR | hsa-miR-320d | Familiar ovarian carcinoma | MNDR-E-MI-39536 |
MNDR | hsa-miR-320d | B-cell lymphoma | MNDR-E-MI-39537 |
MNDR | hsa-miR-320d | Rheumatoid arthritis | MNDR-E-MI-39538 |
MNDR | hsa-miR-320d | Retinoblastoma | MNDR-E-MI-39539 |
MNDR | hsa-miR-320d | Skin cutaneous melanoma | MNDR-E-MI-39540 |
MNDR | hsa-miR-320d | Skin melanoma | MNDR-E-MI-39541 |
MNDR | hsa-miR-320d | Colorectal cancer | MNDR-E-MI-39542 |
MNDR | hsa-miR-320d | Stroke lacunar | MNDR-E-MI-39543 |
MNDR | hsa-miR-320d | Breast cancer her3+ negative | MNDR-E-MI-39544 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABHD13 | Homo sapiens | RR00025355 |
TOP